Maze Therapeutics, Inc. (MAZE)

Maze Therapeutics Statistics

Total Valuation

MAZE has a market cap or net worth of $1.40 billion. The enterprise value is $1.16 billion.

Market Cap	1.40B
Enterprise Value	1.16B

Important Dates

The next estimated earnings date is Friday, November 14, 2025, after market close.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

MAZE has 43.85 million shares outstanding. The number of shares has increased by 727.28% in one year.

Current Share Class	43.85M
Shares Outstanding	43.85M
Shares Change (YoY)	+727.28%
Shares Change (QoQ)	+52.99%
Owned by Insiders (%)	1.36%
Owned by Institutions (%)	27.74%
Float	16.24M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	248.35
Forward PS	n/a
PB Ratio	5.37
P/TBV Ratio	5.35
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	465.65
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 13.63, with a Debt / Equity ratio of 0.10.

Current Ratio	13.63
Quick Ratio	13.29
Debt / Equity	0.10
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -62.95% and return on invested capital (ROIC) is -32.36%.

Return on Equity (ROE)	-62.95%
Return on Assets (ROA)	-30.29%
Return on Invested Capital (ROIC)	-32.36%
Return on Capital Employed (ROCE)	-44.37%
Revenue Per Employee	$20,000
Profits Per Employee	-$590,384
Employee Count	125
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	-554,000
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	23.38
200-Day Moving Average	n/a
Relative Strength Index (RSI)	74.64
Average Volume (20 Days)	327,479

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, MAZE had revenue of $2.50 million and -$73.80 million in losses. Loss per share was -$3.82.

Revenue	2.50M
Gross Profit	2.50M
Operating Income	-125.83M
Pretax Income	-121.35M
Net Income	-73.80M
EBITDA	-123.00M
EBIT	-125.83M
Loss Per Share	-$3.82

Balance Sheet

The company has $264.54 million in cash and $25.01 million in debt, giving a net cash position of $239.53 million or $5.46 per share.

Cash & Cash Equivalents	264.54M
Total Debt	25.01M
Net Cash	239.53M
Net Cash Per Share	$5.46
Equity (Book Value)	262.24M
Book Value Per Share	5.98
Working Capital	251.25M

Cash Flow

In the last 12 months, operating cash flow was -$105.23 million and capital expenditures -$1.40 million, giving a free cash flow of -$106.63 million.

Operating Cash Flow	-105.23M
Capital Expenditures	-1.40M
Free Cash Flow	-106.63M
FCF Per Share	-$2.43

Margins

Gross Margin	100.00%
Operating Margin	-5,033.20%
Pretax Margin	-4,854.00%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MAZE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-727.28%
Shareholder Yield	-727.28%
Earnings Yield	-5.26%
FCF Yield	-7.60%

Analyst Forecast

The average price target for MAZE is $33.83, which is 6.02% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$33.83
Price Target Difference	6.02%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

MAZE has an Altman Z-Score of 4.71 and a Piotroski F-Score of 1.

Altman Z-Score	4.71
Piotroski F-Score	1